Literature DB >> 27495389

Hsp90 directly interacts, in vitro, with amyloid structures and modulates their assembly and disassembly.

Claire Schirmer1, Eléonore Lepvrier1, Laurence Duchesne2, Olivier Decaux1, Daniel Thomas1, Christian Delamarche1, Cyrille Garnier3.   

Abstract

BACKGROUND: The 90kDa heat shock protein (Hsp90) participates in regulating the homeostasis of cellular proteins and was considered one of the key chaperones involved in the control and regulation of amyloid deposits. Hsp90 interacts with the amyloid protein tau through tau aggregation-prone regions, including the VQIVYK hexapeptide motif. This hexapeptide, which self-aggregates, forming amyloid fibrils, is widely used to model amyloid formation mechanisms. Despite evidence showing that Hsp90 interacts directly with Ac-VQIVYK-NH2, its role in the hexapeptide fibrillation process and its binding to peptide structures have not yet been determined.
METHODS: Various biochemical and biophysical techniques, including ultracentrifugation, spectrophotometry, spectrofluorimetry, and electron microscopy, were employed to assess the effects of Hsp90 on Ac-VQIVYK-NH2 assembly and disassembly processes.
RESULTS: At sub-stoichiometric concentrations, Hsp90 bound directly to Ac-VQIVYK-NH2 amyloid structures in vitro, with each Hsp90 dimer interacting with an amyloid structure made of around 50 hexapeptide subunits. Hsp90 inhibited Ac-VQIVYK-NH2 assembly by increasing the critical concentrations of Ac-VQIVYK-NH2 required for assembly. Hsp90 also inhibited the disassembly of Ac-VQIVYK-NH2 amyloid fibrils and promoted their rescue.
CONCLUSIONS: A model explaining the dual effect of Hsp90 on the Ac-VQIVYK-NH2 amyloid fibrillation process has been proposed. GENERAL SIGNIFICANCE: These in vitro results provide new insights into the possible roles of molecular chaperones in modulating amyloid structures by limiting the spread of toxic species.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ac-VQIVYK-NH(2) peptide; Amyloid proteins; Chaperones; Fibrils; Hsp90

Mesh:

Substances:

Year:  2016        PMID: 27495389     DOI: 10.1016/j.bbagen.2016.07.033

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Modulation of Amyloid States by Molecular Chaperones.

Authors:  Anne Wentink; Carmen Nussbaum-Krammer; Bernd Bukau
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

2.  Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis.

Authors:  Melania Filareti; Silvia Luotti; Laura Pasetto; Mauro Pignataro; Katia Paolella; Paolo Messina; Elisabetta Pupillo; Massimiliano Filosto; Christian Lunetta; Jessica Mandrioli; Giuseppe Fuda; Andrea Calvo; Adriano Chiò; Massimo Corbo; Caterina Bendotti; Ettore Beghi; Valentina Bonetto
Journal:  Front Mol Neurosci       Date:  2017-04-06       Impact factor: 5.639

3.  Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity.

Authors:  Longze Sha; Ting Chen; Yu Deng; Tingfu Du; Kaili Ma; Wanwan Zhu; Yan Shen; Qi Xu
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

4.  Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway.

Authors:  Mu Zhang; Cheng Qian; Zu-Guo Zheng; Fei Qian; Yanyan Wang; Pyone Myat Thu; Xin Zhang; Yaping Zhou; Lifan Tu; Qingling Liu; Hui-Jun Li; Hua Yang; Ping Li; Xiaojun Xu
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556

5.  Increased levels of Stress-inducible phosphoprotein-1 accelerates amyloid-β deposition in a mouse model of Alzheimer's disease.

Authors:  Rachel E Lackie; Jose Marques-Lopes; Valeriy G Ostapchenko; Sarah Good; Wing-Yiu Choy; Patricija van Oosten-Hawle; Stephen H Pasternak; Vania F Prado; Marco A M Prado
Journal:  Acta Neuropathol Commun       Date:  2020-08-21       Impact factor: 7.801

6.  Modulation of aggregation with an electric field; scientific roadmap for a potential non-invasive therapy against tauopathies.

Authors:  Gaurav Pandey; Sudhir Morla; Harshal B Nemade; Sachin Kumar; Vibin Ramakrishnan
Journal:  RSC Adv       Date:  2019-02-06       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.